Digital Health Investment Weekly Report Vol.168 Highlights Surge in Global Funding and IPO Filing

Due to recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the homepage of the official account to get the latest trends and expert insights in the digital healthcare industry第一时间!

01 Global Digital Health Investment and Financing Overview

Healthcare Workflow Automation Platform Developer Tennr Secures $101 Million in Series C Funding

On June 18, Tennr, a developer of healthcare workflow automation platforms, secured $101 million in Series C funding led by IVP, with participation from Andreessen Horowitz, Lightspeed, GV, ICONIQ, Foundation Capital, and Frank Slootman. The funds will be used to launch Tennr Network, a new coordination layer that connects all stakeholders in the referral process, providing them with real-time visibility.

Medical Technology Robot Developer Wandercraft Secures $75 Million in Series D Funding

On June 11, medical technology robotics developer Wandercraft secured $75 million in Series D funding, led by Renault Group, PSIM Fund, Teampact Ventures, and others. The funds will be used to accelerate the global rollout of its AI-driven robotics technologies, including launching the world’s first self-balancing personal exoskeleton Eve (as early as 2026), expanding clinical applications for its flagship rehabilitation system Atalante X, and developing and deploying its humanoid robot Calvin-40.

Healthcare Platform Service Provider Nabla Secures $70 Million in Series C Funding

On June 17, healthcare platform service provider Nabla secured $70 million in Series C funding, led by HV Capital with Highland Europe joining as a major investor. DST Global, along with existing investors Cathay Innovation and T Build Collective, also participated. The funds will be used to accelerate product development, drive growth in Nabla’s technology, clinical, and marketing teams, and support strategic partnerships to expand into new care areas.

Corvia Medical, a developer of cardiac devices, secures $55 million in financing

On June 17, Corvia Medical, a developer of cardiac devices, secured $55 million in funding from Third Rock Ventures, General Catalyst Partners, AccelMed, and others. The proceeds will be used to complete the confirmatory clinical trial of its atrial shunt system for heart failure treatment and to support the submission of regulatory filings to the FDA.

Visby Medical, a PCR Diagnostic Test Product Developer, Secures $55 Million in Financing

On June 17, Visby Medical, a developer of PCR diagnostic testing products, secured $55 million in funding led by Catalio Capital Management, with participation from existing investors such as ND Capital. The funds will be used to accelerate the launch of its at-home female sexual health testing product, which has received FDA authorization to detect chlamydia, gonorrhea, and trichomoniasis, providing results within 30 minutes via a connected smartphone application.

Voice Vital Signs Developer Ellipsis Health Raises $45 Million in Series A Funding

On June 13, Ellipsis Health, a developer of voice vital signs, secured $45 million in Series A funding. The round was led by Salesforce, Khosla Ventures, and CVS Health Ventures, with participation from previous investors Mitsui Global Investment, Collier, E12, and AME Cloud Ventures. The funds will be used to further develop its AI care management platform, expand market reach, and continue enhancing its AI voice agent technology to better meet the needs of the healthcare industry.

Digital Remote Physical Therapy Service Provider Sword Health Secures $40 Million in Funding

On June 17, digital remote physical therapy service provider Sword Health secured $40 million in funding from investors including Khosla Ventures, Comcast Ventures, Lince Capital, Oxy Capital, Armilar, Indico Capital, and Shilling. The funds will be used to accelerate Sword Health's momentum in mergers and acquisitions, support its global expansion, and drive the ongoing development of foundational AI models across major care areas.

Glytec, a provider of digital therapeutics for diabetes, secures $36 million in funding

On June 18, Glytec, a provider of digital therapeutics for diabetes, secured $36 million in funding led by Savitr Capital and Hayfin Capital Management. The funds will be used to drive the continued expansion of Glytec's platform, including its flagship product, the Glucommander® SaaS solution, and to accelerate the development of innovative new technologies.

AI Medical Imaging Solutions Provider HOPPR Secures $31.5 Million in Series A Funding

On June 17, HOPPR, a provider of AI medical imaging solutions, secured $31.5 million in Series A funding led by Kivu and Greycroft, with participation from PSG Equity, Morningside Capital, Fortitude Ventures, and existing investor Health 2047. The funds will be used to accelerate HOPPR's innovation and expansion in the field of AI medical imaging and to further develop and apply its platform.

Medical Device Procurement Platform SDP Japan Secures $31 Million in Series D Funding

On June 15, SDP Japan, a medical device procurement platform, secured $31 million in Series D funding led by Japan Post Investment, with participation from investors such as Sumitomo Mitsui Trust Investment. The funds will be used to strengthen SDP Japan's growth platform, promote advanced surgical care models to underserved areas, and collaborate closely with various stakeholders in the healthcare ecosystem to rebuild medical infrastructure in regional cities.

Autonomize AI, an AI solutions provider for healthcare and life sciences organizations, raises $28 million in Series A funding

On June 12, Autonomize AI, a provider of AI solutions for healthcare and life sciences organizations, secured $28 million in Series A funding led by Valtruis and The Cigna Group Ventures, with participation from existing investors such as Asset Management Ventures. The funds will be used to expand agent AI technology in the healthcare and life sciences sectors, helping medical institutions reduce administrative complexity, enhance clinicians' capabilities, and improve care delivery outcomes.

Integrated Healthcare Platform Commons Clinic Secures $26 Million in Series B Funding

On June 12, integrated healthcare platform Commons Clinic secured $26 million in Series B funding, led by RA Capital with participation from Floating Point, SteelSky Ventures, and others. The funds will be used to launch the Wholebody multi-specialty healthcare platform, which integrates all of the organization’s advanced preventive care services. Through early detection, personalized prevention, and responsible intervention, this platform further advances Commons Clinic’s mission to redefine specialty care.

Endovascular Treatment Device Developer Aortyx Secures €13.8M in Series A Funding

On June 12, Aortyx, a developer of endovascular treatment devices, secured €13.8 million in Series A funding led by Ship2B Ventures and Clave Capital, with participation from Nara Capital. Aortyx aims to improve aortic repair using patches that gradually absorb within the body, potentially reducing complications associated with permanent implants. The funds will be used to prepare for the first-in-human trials of this bioresorbable aortic patch.

Biomedical Device Developer Ceryx Medical Secures $15 Million in Financing

On June 14, Ceryx Medical, a biomedical device developer, secured $15 million in funding from investors including BGF, Parkwalk Advisors, Development Bank of Wales, and BBI. This round of financing will accelerate the development of its permanent pacing platform, redefining heart failure treatment.

ABM Respiratory Care, a provider of respiratory care solutions, secures $14.8 million in Series B funding

On June 17, ABM Respiratory Care, a provider of respiratory care solutions, secured $14.8 million in Series B funding, led by Peter Soderberg, Managing Partner of Worthy Venture Resources, LLC, with participation from Bluwave Capital, LLC, among others. The funds will be used to accelerate the commercialization of its airway clearance system, BiWaze® Clear, expand sales efforts in the United States, invest in clinical research, and enhance patient engagement and digital health capabilities.

Peripheral Vascular Intervention High-End Device Developer Meichuang Medical Secures 100 Million Yuan in Equity Financing

On June 13, peripheral vascular interventional high-end device developer Meichuang Medical secured RMB 100 million in equity financing from investors including Suzhou Venture Capital, Paradise Silicon, Guanghua Wutong, and Medpark. This round of financing will be used for the clinical trials, registration, and commercialization layout of self-developed products, accelerating the globalization process.

Microsurgical Robotics Platform Developer Dishi Medical Secures Nearly RMB100 Million in Series A Funding

On June 16, D. Sight Medical, a developer of microsurgical robot platforms, secured nearly RMB 100 million in Series A financing led by Panthera Capital, with participation from Shangcheng Capital, Jinhé Capital, and Hangzhou Science and Technology Innovation Group. The funds will be used to accelerate the clinical registration of general microsurgical robots and the commercial promotion of ophthalmic surgical robot products, further solidifying the technological advantages of D. Sight Medical's core products and enhancing the robotic micro-operation product ecosystem.

Pathology Analysis Service Provider PreciseDx Secures $11 Million in Financing

On June 18, pathology analysis service provider PreciseDx secured $11 million in funding, led by Eventide Asset Management, Merck Global Health Innovation Fund, and Philips Ventures, with participation from Labcorp, Quest Diagnostics, and others. The funds will be used to advance the company's ongoing clinical data collection and commercial expansion.

Somnee, a developer of sleep wearables, secures $10 million in seed funding

On June 11, Somnee, a developer of sleep wearable devices, secured $10 million in seed funding led by Khosla Ventures, with participation from Marc Benioff's TIME Ventures. The funds will be used to advance its AI-driven neurotechnology sleep wearable device and help the company launch its second-generation smart sleep headband.

Positrigo, a developer of brain PET scanners, secures CHF 7 million in funding

On June 13, Positrigo, a developer of brain PET scanners, secured CHF 7 million in funding led by HealthCap and Navivo, with participation from existing shareholders and multiple family offices and individuals. The proceeds will support production and accelerate the commercialization of its brain imaging device, the NeuroLF system.

Animal Robotics Developer Tombot Secures $6.1 Million in Series A Funding

On June 18, animal robotics developer Tombot secured $6.1 million in Series A funding, led by Caduceus Capital Partners. Originally designed to meet the specific medical needs of dementia patients, the Tombot puppy is now also being preordered for use with autistic children. The funds will be used to expand the team, finalize engineering design, and obtain regulatory and safety certifications.

Digital Health Platform Quilt Health Raises $6 Million in Seed Funding

On June 17, digital health platform Quilt Health secured $6 million in seed funding, led by MaC Venture Capital and Underscore Ventures, with participation from Meridian Street Capital. The funds will be used to accelerate product development, drive R&D efforts, and expand the Quilt Health team while focusing on collaborations with high-quality health systems in regions of the U.S. that have traditionally not benefited from significant life science investments.

Corvia Medical Partners with Zhihui Eye and Laolai Health to Build a New Healthcare Ecosystem

On June 19, Corvia Medical, Inc., Zhihui Eye Technology Co., Ltd., and Laolai Health Technology Group Co., Ltd. signed a strategic cooperation agreement. By integrating AI technology, smart hardware development, and the operational advantages of internet platforms, they aim to create an innovative closed-loop for medical and health services. The collaboration will enhance the intelligence, personalization, and accessibility of medical services, while jointly developing a new generation of AI medical terminals and establishing a complete health management service chain.

Lilly Partners with Juvena Therapeutics, Novo Nordisk Collaborates with Deep Apple Therapeutics to Advance AI-Driven Weight Loss Drug Development

On June 11, Eli Lilly and Juvena Therapeutics reached a global exclusive license and multi-target research collaboration agreement worth over $650 million. Juvena's AI-driven platform, JuvNET, is capable of mining therapeutic proteins with muscle-protective and regenerative properties from a proprietary library of human stem cell-secreted proteins, providing support for the development of Lilly’s next-generation weight loss drugs. On the same day, Novo Nordisk and Deep Apple Therapeutics reached an $812 million research collaboration and global exclusive license agreement. Deep Apple’s AI-driven platform combines machine learning-driven virtual screening with cryo-electron microscopy (cryo-EM)-supported structural biology to discover and optimize oral small-molecule drugs targeting non-incretin G protein-coupled receptors (GPCRs), offering support for the development of Novo Nordisk’s next-generation weight loss drugs.

Surgical Instrument Sterilization Service Provider Instrumentum Acquires Sterile Processing Express

On June 11, Instrumentum, a surgical instrument sterilization service provider, acquired Sterile Processing Express, a sterile processing service provider. This strategic acquisition expands Instrumentum's operational footprint to five facilities across four states, significantly enhancing its ability to meet the growing off-site sterile processing needs driven by the increasing demand for elective surgeries in hospitals, clinics, and ambulatory surgery centers (ASCs).

Pharmacy Benefits Management Solutions Provider Capital Rx Acquires Amino Health

On June 11, Capital Rx, a provider of pharmacy benefits management solutions, acquired Amino Health, a provider of healthcare guidance platforms. Amino Health will become Capital Rx's care navigation solution "Judi Care," extending Capital Rx's enterprise platform capabilities to nearly 60 million insured individuals in its portfolio. Through Amino Health, Capital Rx now offers employers all the components needed to create comprehensive benefits plan designs and addresses care barriers affecting millions of Americans.

ArteryNet/Arterial Orange Industry Think Tank/Huaxing Capital/BGI Co-Win/Rock Health/Mobile Health News/Fierce Health, etc.

Compiled by: Hou Zhancan, Huang Changjian‍‍‍

Share

Like

Click to view